Correlation Between Eyenovia and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Transcode Therapeutics, you can compare the effects of market volatilities on Eyenovia and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Transcode Therapeutics.
Diversification Opportunities for Eyenovia and Transcode Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Eyenovia and Transcode is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Eyenovia i.e., Eyenovia and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Eyenovia and Transcode Therapeutics
Given the investment horizon of 90 days Eyenovia is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eyenovia is 1.23 times less risky than Transcode Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 71.00 in Transcode Therapeutics on August 27, 2024 and sell it today you would lose (33.00) from holding Transcode Therapeutics or give up 46.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyenovia vs. Transcode Therapeutics
Performance |
| Timeline |
| Eyenovia |
| Transcode Therapeutics |
Eyenovia and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyenovia and Transcode Therapeutics
The main advantage of trading using opposite Eyenovia and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Eyenovia vs. Capricor Therapeutics | Eyenovia vs. Soleno Therapeutics | Eyenovia vs. Bio Path Holdings | Eyenovia vs. Moleculin Biotech |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |